Patents by Inventor Raja Sekhar VOGURI

Raja Sekhar VOGURI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Solid dispersions of amorphous Lumateperone p-Tosylate
    Patent number: 11292793
    Abstract: The present application relates to solid state forms of Lumateperone p-Tosylate and processes for preparation thereof. The present application provides amorphous Lumateperone p-tosylate and a solid dispersion comprising amorphous Lumateperone p-tosylate and one or more pharmaceutically acceptable polymers and processes for preparation thereof. The compounds are useful as 5-HT2 receptor agonists and antagonists used in treating disorders of the central nervous system including a disorder associated with 5HT2C or 5HT2A receptor modulation.
    Type: Grant
    Filed: April 9, 2018
    Date of Patent: April 5, 2022
    Assignee: DR. REDDY'S LABORATORIES LIMITED
    Inventors: Vishweshwar Peddy, Raja Sekhar Voguri
  • Solid forms of acalabrutinib and process for preparation thereof
    Patent number: 10717740
    Abstract: The present application relates to crystalline propylene glycol solvate of acalabrutinib and process for preparation thereof. The propylene glycol solvate of acalabrutinib may be selected from a group of racemic propylene glycol solvate, R-propylene glycol solvate and S-propylene glycol solvate of acalabrutinib. Specifically, the present application relates to crystalline forms RSV1, RSV2, RSV3 and RSV4 of acalabrutinib. Crystalline forms RSV2 and RSV3 are stable in all conditions and has excellent physico-chemical properties. The present application also relates to crystalline form RSVS of acalabrutinib.
    Type: Grant
    Filed: June 8, 2018
    Date of Patent: July 21, 2020
    Assignee: DR. REDDY'S LABORATORIES LIMITED.
    Inventors: Raja Sekhar Voguri, Vishweshwar Peddy
  • SOLID FORMS OF ACALABRUTINIB AND PROCESS FOR PREPARATION THEREOF
    Publication number: 20200199130
    Abstract: The present application relates to crystalline propylene glycol solvate of acalabrutinib and process for preparation thereof. The propylene glycol solvate of acalabrutinib may be selected from a group of racemic propylene glycol solvate, R-propylene glycol solvate and S-propylene glycol solvate of acalabrutinib. Specifically, the present application relates to crystalline forms RSV1, RSV2, RSV3 and RSV4 of acalabrutinib. Crystalline forms RSV2 and RSV3 are stable in all conditions and has excellent physico-chemical properties. The present application also relates to crystalline form RSV5 of acalabrutinib.
    Type: Application
    Filed: June 8, 2018
    Publication date: June 25, 2020
    Inventors: Raja Sekhar VOGURI, Vishweshwar PEDDY
  • AMORPHOUS FORM AND SOLID DISPERSIONS OF LUMATEPERONE p-TOSYLATE
    Publication number: 20200148683
    Abstract: The present application relates to solid state forms of Lumateperone p-Tosylate and processes for preparation thereof. The present application provides amorphous Lumateperone p-tosylate and a solid dispersion comprising amorphous Lumateperone p-tosylate and one or more pharmaceutically acceptable polymers, their processes. The amorphous form and amorphous solid dispersions of the present application can be reproduced easily and is amenable for processing into a dosage form.
    Type: Application
    Filed: April 9, 2018
    Publication date: May 14, 2020
    Inventors: Vishweshwar PEDDY, Raja Sekhar VOGURI